We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Fast, Cheap, and Easy Testing Method Could Become a Game-Changer in Antibiotic Sensitivity Testing

By LabMedica International staff writers
Posted on 26 Apr 2023

Antibiotic resistance, which has become a critical global public health issue, occurs when bacteria evolve to withstand the drugs designed to eliminate them. More...

Antibiotic sensitivity testing (AST) typically involves culture or genetic methods to determine bacterial resistance. Conventional ASTs can take up to 24 hours or longer for slow-growing bacteria, a critical period in clinical settings. Although faster ASTs have been developed, they often require complex and costly equipment. Researchers have now created a rapid, affordable, and accessible method based on optical microscopy that can perform AST at the single-cell level without needing to attach or label bacteria. The technique utilizes a standard optical microscope, a camera or mobile phone, and specialized software.

The new technique developed by researchers at EPFL (Lausanne, Switzerland) and Vrije Universiteit Brussel (Brussels, Belgium) is called optical nanomotion detection (ONMD) and monitors the nanoscale vibrations of individual bacteria before and during antibiotic exposure. Monitoring is performed using a basic optical microscope and a video camera or mobile phone. ONMD observes the microscopic oscillations (nanomotion) of bacterial cells, which signify living organisms and serve as a "signature of life." Nanomotion persists as long as the organism is alive, ceasing immediately upon death. In ONMD, bacterial nanomotion is captured in a video where individual cell movements are monitored with sub-pixel resolution.

Researchers successfully applied ONMD to detect the sensitivity of various bacteria to antibiotics, determining the sensitivities of Escherichia coli, Staphylococcus aureus, Lactobacillus rhamnosus, and Mycobacterium smegmatis (a non-pathogenic bacterial model for tuberculosis) sensitivities to antibiotics like ampicillin, streptomycin, doxycycline, and vancomycin in under two hours. ONMD not only tracks bacteria's life-death transitions upon antibiotic exposure but also reveals changes in bacterial metabolism due to nutrient availability. Tests demonstrated that ONMD can quickly and simply evaluate bacterial sensitivity or resistance to antibiotics by monitoring cellular oscillations. The researchers believe that the method's simplicity and effectiveness make it a game-changer in AST, with far-reaching implications for clinical and research applications, as it can be applied to a wide variety of bacteria.

“We have developed a technique in our laboratories that allows us to obtain an antibiogram within 2-4 hours – instead of the current 24 hours for the most common germs and one month for tuberculosis,” said Dr. Sandor Kasas at EPFL.

“Our technique is not only faster but also simpler and much cheaper than all those existing now,” added Professor Ronnie Willaert at Vrije Universiteit Brussel.

Related links:
EPFL
Vrije Universiteit Brussel


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Connectivity Solution
EKF Link
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.